WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: XYREM (SODIUM OXYBATE) ORAL SOLUTION CIII

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on XYREM (SODIUM OXYBATE) ORAL SOLUTION CIII

Mark Identification

Proof of use for XYREM (SODIUM OXYBATE) ORAL SOLUTION CIII

We do not have any records of a proof of use for XYREM (SODIUM OXYBATE) ORAL SOLUTION CIII at this moment.

Click here to add a proof of use for XYREM (SODIUM OXYBATE) ORAL SOLUTION CIII

Possible trademark infringements of XYREM (SODIUM OXYBATE) ORAL SOLUTION CIII

Basic Information about XYREM (SODIUM OXYBATE) ORAL SOLUTION CIII

Serial Number
76427104
Filing Date
02 Jul 2002
Registration Number
2952351
Registration Date
17 May 2005
Mark Drawing Code
3

Classifications

Declare the trademark use of XYREM (SODIUM OXYBATE) ORAL SOLUTION CIII on the blockchain with WikiTrademarks.io.

First use of XYREM (SODIUM OXYBATE) ORAL SOLUTION CIII anywhere
XYREM (SODIUM OXYBATE) ORAL SOLUTION CIII was first used on 07 Oct 2002 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
005
US Codes
006; 018; 044; 046; 051; 052

Who owns XYREM (SODIUM OXYBATE) ORAL SOLUTION CIII?

1. JAZZ PHARMACEUTICALS, INC. PALO ALTO CA

2. JPI Commercial, LLC Palo Alto CA

3. Orphan Medical, Inc. Minnetonka MN

4. Orphan Medical, Inc. Minnetonka MN

5. Orphan Medical, Inc. Minnetonka MN

Correspondent

Timothy D. Sitzmann
Winthrop & Weinstine, P.A.
Capella Tower Suite 3500
225 South Sixth Street

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on XYREM (SODIUM OXYBATE) ORAL SOLUTION CIII